News
This was the stock's third consecutive day of gains.
TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial ...
Analysts have provided new insights into AbbVie and Esperion, two major players in the healthcare sector. AbbVie’s stock has ...
On June 17, 2025, the Tax Court opinion in AbbVie Inc. and Subsidiaries v. Commissioner of Internal Revenue was ...
LSEG also reported a 78% increase in deals worth more than $10 billion during the first half of 2025, compared to 2024 levels ...
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...
Advance‑decline metrics reveal ~52% of stocks up: modest daily gains, but with a positive trend in new highs (~7%) versus low occurrences (~1%). Broader market participation beyond mega‑cap tech is ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
As noted, Healthcare and Staples are two of the market’s more oversold sectors, which could catch inflows from a risk-off ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results